Results 131 to 140 of about 23,301 (196)

Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy. [PDF]

Blood Adv
Xu R, Wu G, Rice S, Booker M, Weekes J, Bell H, Gao Y, Nirmal AJ, Liu H, Ciantra Z, Luo Q, Fortune A, Whalen K, Guanci T, Wan Y, Louissaint A, Nordberg JJ, Lin JR, Hemann M, Manalis SR, Armand P, Smith E, Jacobson CA, Tolstorukov M, Murakami MA, Sorger PK, Weinstock DM, Song L, Lane AA.   +28 more
europepmc   +1 more source

B-cell receptor signaling and microenvironment crosstalk in mantle cell lymphoma. [PDF]

Cell Commun Signal
Quaglia FM, Gambino S, Galasso M, Vegliante MC, Visco C, Scupoli MT.   +5 more
europepmc   +1 more source

Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy With Subsequent Diagnosis of Mantle Cell Lymphoma. [PDF]

Cureus
Zhao C, Duffield A, Toz B.
europepmc   +1 more source

Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT. [PDF]

Blood Adv
Santoro N, Mooyaart JE, Novak U, Protheroe R, Ayuk F, Dreger P, van Meerten T, Paneesha S, Sanderson R, Ram R, Northend M, Forcade E, Huynh A, Yakoub-Agha I, Hoogenboom JD, Coelho MHM, Pagliuca S, Malard F, Kuball J, Sureda A, Bazarbachi A, Ruggeri A, Rocha V.   +22 more
europepmc   +1 more source

We are on the right track for mantle cell lymphoma. [PDF]

Br J Haematol
Moioli A, Visco C.
europepmc   +1 more source

Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial. [PDF]

Nat Commun
Zhang Y, Nie M, Cao Y, Li Z, Huang H, Li G, Sun X, Liu P, Gao Y, Fang X, Bai B, Cai J, Li L, Liu Y, Peng S, Huang H, Xia Y, Cai Q.   +17 more
europepmc   +1 more source

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry. [PDF]

Blood Cancer J
Cho H, Kato K, Chan JY, Dajung K, Huang H, Cai Q, Lin T, Bunworasate U, Tan SM, Kang KW, Kwak JY, Chen TY, Lee JO, Jeong SH, Do YR, Chan E, Kang HJ, Eom HS, Oh SY, Koh Y, Kim HJ, Kim SH, Won JH, Park YH, Yang DH, Ng SC, Jo JC, Tadjoedin H, Lubis AM, Sutandyo N, Muta T, Takase K, Yoon DH, Kim WS.   +33 more
europepmc   +1 more source

The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma. [PDF]

Sci Rep
Fernández-Garnacho EM, Martínez-Muñoz C, Nadeu F, Clot G, Valero JG, Araujo-Ayala F, Martínez-Farran A, De Bolòs A, Colomer D, Mozas P, Rivero A, Giné E, López-Guillermo A, Salaverria I, López C, Beà S, Amador V, Demajo S, Jares P, Martín-Subero JI, Pérez-Galán P, Campo E, Hernández L.   +22 more
europepmc   +1 more source

Interpretable multimodal PET/CT-EHR fusion via mixture-of-experts for prognostic stratification in mantle cell lymphoma: a multicenter study. [PDF]

BMC Med
Jiang C, Zhang Z, Jiang Z, Ding C, Teng Y, Gao L, Jiang M, Qu L, Tian R.   +8 more
europepmc   +1 more source

<i>TP53</i> Mutations in Mantle Cell Lymphoma: From Backup to Game Changer. [PDF]

J Clin Med
Carazzolo ME, Moioli A, Visco C.
europepmc   +1 more source